City of Oklahoma City v. Purdue Pharma LP et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
Ohio Northern District Court | |
Judge: | Dan Aaron Polster |
Case #: | 1:19-op-45498 |
Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
Cause | 28:1332 Diversity-Personal Injury |
Case Filed: | Jun 18, 2019 |
Case in other court: | Oklahoma Western, 5:19-cv-00076 |
Last checked: Friday Nov 08, 2019 7:55 PM EST |
Defendant
Teva Pharmaceutical Industries Ltd.
|
Represented By
|
Defendant
Mallinckrodt PLC
|
|
Defendant
McKesson Corp.
|
Represented By
|
Defendant
Morris & Dickson Co LLC
|
|
Defendant
Ortho McNeil Janssen Pharmaceuticals Inc
|
Represented By
|
Defendant
Physicians Total Care Inc
|
|
Defendant
Russell Portenoy
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
Defendant
Quest Pharmaceuticals, Inc.
|
Represented By
|
Defendant
Mallinckrodt LLC
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
Defendant
MD William Valuck
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
Defendant
Watson Pharma, Inc.
|
Represented By
|
Defendant
Watson Pharmaceutcals, Inc.
|
|
Defendant
Lynn Webster
|
Represented By
|
Defendant
Mylan Pharmaceuticals, Inc.
781 Chestnut Ridge Road
Morgantown, WV 26505 |
|
Defendant
Par Pharmaceutical Inc.
|
|
Defendant
SpecGX LLC
|
|
Defendant
Walgreens Boots Alliance, Inc., a/k/a Walgreen Co.
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
Defendant
Actavis LLC
|
Represented By
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
Defendant
Actavis plc
|
|
Defendant
Allergan PLC
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
Defendant
Anda Inc
|
Represented By
|
Defendant
Anda Pharmaceuticals, Inc.
|
Represented By
|
Defendant
Cardinal Health Inc.
|
Represented By
|
Defendant
Cephalon Inc.
|
Represented By
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
Defendant
Perry Fine
|
Represented By
|
Defendant
GCP Pharma LLC
|
|
Defendant
Harvard Drug Group LLC The
|
Represented By
|
Defendant
Insys Therapeutics, Inc.
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
Defendant
Harvey Jenkins
|
|
Defendant
Johnson & Johnson
|
Represented By
|
Defendant
Keysource Medical, Inc.
|
|
Plaintiff
City of Oklahoma City, Oklahoma
|
Represented By
|
Docket last updated: 09/12/2019 9:55 AM EDT |
Monday, January 28, 2019 | ||
1 | 1 NOTICE OF REMOVAL from District Court of Oklahoma County, case number CJ-2018-6179 filed by Endo Pharmaceuticals Inc, Endo Health Solutions Inc.(em) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit 1 - JPML Transfer Order, | ||
Att: 2 Exhibit 2 - Service Packet, | ||
Att: 3 Exhibit 3 - Petition, | ||
Att: 4 Exhibit 4 - Return of Service Harvey Jenkins MD, | ||
Att: 5 Exhibit 5 - Answer of William Valuck DO, | ||
Att: 6 Exhibit 6 - Entry of Appearance for Harvey Jenkins MD, | ||
Att: 7 Exhibit 7 - Entry of Appearance for AmeriSourceBergen Corp, | ||
Att: 8 Exhibit 8 - Entry of Appearance for McKesson Corp, | ||
Att: 9 Exhibit 9 - Special App and Mtn for Ext by McKesson Corp, Cardinal Health, AmeriSourceBergen Corp, | ||
Att: 10 Exhibit 10 - Entry of Appearance for Cardinal Health Inc, | ||
Att: 11 Exhibit 11 - Docket Sheet Oklahoma County, | ||
Att: 12 Civil Cover Sheet | ||
Tuesday, January 29, 2019 | ||
PAYMENT FOR A CIVIL CASE Filing fee $ 400, receipt number 1087-2854725. (Zschiesche, Raymond) [Transferred from okwd on 6/18/2019.] | ||
Wednesday, January 30, 2019 | ||
2 | 2 ENTRY of Appearance by D Michael McBride, III on behalf of Amerisourcebergen Corporation (McBride, D) [Transferred from okwd on 6/18/2019.] | |
3 | 3 ENTRY of Appearance by Susan E Huntsman on behalf of Amerisourcebergen Corporation (Huntsman, Susan) [Transferred from okwd on 6/18/2019.] | |
4 | 4 DISCLOSURE STATEMENT - CORPORATE by Amerisourcebergen Corporation . (Huntsman, Susan) [Transferred from okwd on 6/18/2019.] | |
5 | 5 ENTRY of Appearance by Raymond E Zschiesche on behalf of Endo Health Solutions Inc, Endo Pharmaceuticals Inc (Zschiesche, Raymond) [Transferred from okwd on 6/18/2019.] | |
6 | 6 DISCLOSURE STATEMENT - CORPORATE by Endo Health Solutions Inc, Endo Pharmaceuticals Inc . (Zschiesche, Raymond) [Transferred from okwd on 6/18/2019.] | |
Thursday, January 31, 2019 | ||
7 | 7 ENTRY of Appearance by Stuart D Campbell on behalf of McKesson Corp (Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
8 | 8 DISCLOSURE STATEMENT - CORPORATE by McKesson Corp . (Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
9 | 9 ENTRY of Appearance by Ryan A Ray on behalf of Cardinal Health Inc (Ray, Ryan) [Transferred from okwd on 6/18/2019.] | |
10 | 10 DISCLOSURE STATEMENT - CORPORATE by Cardinal Health Inc . (Ray, Ryan) [Transferred from okwd on 6/18/2019.] | |
11 | 11 ENTRY of Appearance by Kaylee P Davis-Maddy on behalf of McKesson Corp (Davis-Maddy, Kaylee) [Transferred from okwd on 6/18/2019.] | |
Friday, February 01, 2019 | ||
12 | 12 ORDER OF RECUSAL. Signed by Honorable Robin J. Cauthron on 02/01/19. (wh) [Transferred from okwd on 6/18/2019.] | |
13 | 13 ORDER REASSIGNING CASE. Case reassigned to Honorable Charles Goodwin for all further proceedings. Honorable Robin J. Cauthron no longer assigned to case. Signed by Honorable Robin J. Cauthron on 02/01/19. (wh) [Transferred from okwd on 6/18/2019.] | |
Monday, February 04, 2019 | ||
14 | 14 ENTRY of Appearance by John H Sparks on behalf of Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho McNeil Janssen Pharmaceuticals Inc (Sparks, John) [Transferred from okwd on 6/18/2019.] | |
15 | 15 ENTRY of Appearance by Michael W Ridgeway on behalf of Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho McNeil Janssen Pharmaceuticals Inc (Ridgeway, Michael) [Transferred from okwd on 6/18/2019.] | |
16 | 16 DISCLOSURE STATEMENT - CORPORATE by Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho McNeil Janssen Pharmaceuticals Inc . (Ridgeway, Michael) [Transferred from okwd on 6/18/2019.] | |
17 | 17 MOTION for Extension of Time to file Responsive Pleadings by Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho McNeil Janssen Pharmaceuticals Inc. (Ridgeway, Michael) [Transferred from okwd on 6/18/2019.] | |
18 | 18 UNOPPOSED MOTION for Extension of Time to File Answer by Amerisourcebergen Corporation, Cardinal Health Inc, McKesson Corp. (Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
Wednesday, February 06, 2019 | ||
19 | 19 ENTRY of Appearance by Sanford C Coats on behalf of The Purdue Frederick Company Inc, Purdue Pharma Inc, Purdue Pharma LP (Coats, Sanford) [Transferred from okwd on 6/18/2019.] | |
20 | 20 ENTRY of Appearance by Joshua D Burns on behalf of The Purdue Frederick Company Inc, Purdue Pharma Inc, Purdue Pharma LP (Burns, Joshua) [Transferred from okwd on 6/18/2019.] | |
21 | 21 AMENDED MOTION for Extension of Time to file Responsive Pleadings by Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho McNeil Janssen Pharmaceuticals Inc.(Ridgeway, Michael) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit 1 | ||
22 | 22 ENTRY of Appearance by Jennifer N Lamirand on behalf of The Purdue Frederick Company Inc, Purdue Pharma Inc, Purdue Pharma LP (Lamirand, Jennifer) [Transferred from okwd on 6/18/2019.] | |
23 | 23 DISCLOSURE STATEMENT - LLC by Purdue Pharma LP . (Lamirand, Jennifer) [Transferred from okwd on 6/18/2019.] | |
24 | 24 DISCLOSURE STATEMENT - CORPORATE by Purdue Pharma Inc . (Lamirand, Jennifer) [Transferred from okwd on 6/18/2019.] | |
25 | 25 DISCLOSURE STATEMENT - CORPORATE by The Purdue Frederick Company Inc . (Lamirand, Jennifer) [Transferred from okwd on 6/18/2019.] | |
Thursday, February 07, 2019 | ||
26 | 26 ORDER granting21 AMENDED MOTION for Extension of Time to file Responsive Pleadings filed by Janssen Pharmaceuticals Inc, Janssen Pharmaceutica Inc, Johnson & Johnson, Ortho McNeil Janssen Pharmaceuticals Inc and18 UNOPPOSED MOTION for Extension of Time to File Answer filed by Amerisourcebergen Corporation, Cardinal Health Inc, McKesson Corp as set forth herein. Signed by Honorable Charles Goodwin on 02/07/2019. (jb) [Transferred from okwd on 6/18/2019.] | |
27 | 27 ENTRY of Appearance by D Todd Riddles on behalf of Quest Pharmaceuticals Inc (Riddles, D) [Transferred from okwd on 6/18/2019.] | |
28 | 28 DISCLOSURE STATEMENT - CORPORATE by Quest Pharmaceuticals Inc . (Riddles, D) [Transferred from okwd on 6/18/2019.] | |
29 | 29 NOTICE (other) by McKesson Corp Supplemental Notice of Removal(Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit Docket, | ||
Att: 2 Exhibit Petition, | ||
Att: 3 Exhibit Return, | ||
Att: 4 Exhibit Answer, | ||
Att: 5 Exhibit Entry, | ||
Att: 6 Exhibit Entry, | ||
Att: 7 Exhibit Entry, | ||
Att: 8 Exhibit Motion, | ||
Att: 9 Exhibit Order, | ||
Att: 10 Exhibit Entry, | ||
Att: 11 Exhibit Notice of Notice, | ||
Att: 12 Exhibit Authorities | ||
Friday, February 08, 2019 | ||
30 | 30 UNOPPOSED MOTION for Extension of Time to Answer, Move, or Otherwise Respond to Petition under Rule 12 by Quest Pharmaceuticals Inc. (Riddles, D) [Transferred from okwd on 6/18/2019.] | |
Wednesday, February 13, 2019 | ||
31 | 31 ORDER re21 AMENDED MOTION for Extension of Time to file Responsive Pleadings . The Court additionally grants the Amended Motion as to the Manufacturer Defendants. The Janssen Defendants and the Manufacturer Defendants identified in Doc. No. 21-1 shall file their answer or otherwise respond to plaintiff's petition within 45 days of a decision by the Judicial Panel on Multidistrict Litigation granting a motion to vacate a conditional transfer order covering this action or otherwise finally denying transfer of this action, or this Court's ruling on any motion to remand, whichever is later. Signed by Honorable Charles Goodwin on 02/13/2019. (jb) [Transferred from okwd on 6/18/2019.] | |
32 | 32 ORDER granting30 Motion for Extension of Time. Defendant Quest Pharmaceuticals, Inc. shall file its answer or otherwise respond to plaintiff's petition within 45 days of a decision by the Judicial Panel on Multidistrict Litigation granting a motion to vacate a conditional transfer order covering this action or otherwise finally denying transfer of this action, or this Court's ruling on any motion to remand, whichever is later. Signed by Honorable Charles Goodwin on 02/13/2019. (jb) [Transferred from okwd on 6/18/2019.] | |
Thursday, February 14, 2019 | ||
33 | 33 ENTRY of Appearance by Nicholas V Merkley on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (Merkley, Nicholas) [Transferred from okwd on 6/18/2019.] | |
34 | 34 DISCLOSURE STATEMENT - CORPORATE by Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc . (Merkley, Nicholas) [Transferred from okwd on 6/18/2019.] | |
35 | 35 ENTRY of Appearance by Ashley E Quinn on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (Quinn, Ashley) [Transferred from okwd on 6/18/2019.] | |
36 | 36 UNOPPOSED MOTION for Extension of Time to File Answer Move, or Otherwise Respond by Anda Inc, Anda Pharmaceuticals Inc. (Hemphill, Lisa) [Transferred from okwd on 6/18/2019.] | |
37 | 37 CERTIFICATE of Appearance . (Hemphill, Lisa) [Transferred from okwd on 6/18/2019.] | |
Thursday, February 21, 2019 | ||
38 | 38 MOTION to Remand to State Court by Oklahoma City City of.(Court, Todd) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit 1- Order - Trotter v. Smith et al., | ||
Att: 2 Exhibit 2 - Order - Adams v. Wyeth | ||
39 | 39 ORDER granting36 UNOPPOSED MOTION for Extension of Time to File Answer Move, or Otherwise Respond filed by Anda Pharmaceuticals Inc, Anda Inc. Defendants Anda, Inc. and Anda Pharmaceuticals, Inc. shall answer or otherwise respond to plaintiff's petition within 45 days of a decision by the Judicial Panel on Multidistrict Litigation granting a motion to vacate a conditional transfer order covering this action or otherwise finally denying transfer of this action, or this Court's ruling on any motion to remand, whichever is later. Signed by Honorable Charles Goodwin on 02/21/2019. (jb) [Transferred from okwd on 6/18/2019.] | |
40 | 40 MOTION to Expedite Briefing by Oklahoma City City of. (Court, Todd) [Transferred from okwd on 6/18/2019.] | |
41 | 41 ENTRY of Appearance by Jeffrey A Curran on behalf of Anda Inc, Anda Pharmaceuticals Inc (Curran, Jeffrey) [Transferred from okwd on 6/18/2019.] | |
Monday, February 25, 2019 | ||
42 | 42 RESPONSE in Opposition re40 MOTION to Expedite Briefing filed by Amerisourcebergen Corporation, Cardinal Health Inc, Endo Health Solutions Inc, Endo Pharmaceuticals Inc, McKesson Corp. (Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
43 | 43 JOINT MOTION to Stay Case Proceedings Pending Likely Transfer to Multidistrict Litigation by Amerisourcebergen Corporation, Cardinal Health Inc, McKesson Corp.(Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit 1 - CTO, | ||
Att: 2 Exhibit 2 - Wis. Stay Order, | ||
Att: 3 Exhibit 3 - Cal. Stay Order 1, | ||
Att: 4 Exhibit 4 - Ky. Stay Order, | ||
Att: 5 Exhibit 5 - 6 Cty Transfer Order, | ||
Att: 6 Exhibit 6 - Cherokee Nation Transfer Order, | ||
Att: 7 Exhibit 7 - Delaware OK Stay Order, | ||
Att: 8 Exhibit 8 - Pawnee OK Stay Order, | ||
Att: 9 Exhibit 9 - Osage OK Stay Order, | ||
Att: 10 Exhibit 10 - Portland ME Stay Order, | ||
Att: 11 Exhibit 11 - EDVA Stay Order, | ||
Att: 12 Exhibit 12 - WDVA Stay Order, | ||
Att: 13 Exhibit 13 - Cal. Stay Order, | ||
Att: 14 Exhibit 14 - Ill. Stay Order 1, | ||
Att: 15 Exhibit 15 - Fla. Deferral Order, | ||
Att: 16 Exhibit 16 - Ariz. Partial Stay Order | ||
Wednesday, February 27, 2019 | ||
44 | 44 DISCLOSURE STATEMENT - CORPORATE by Anda Inc, Anda Pharmaceuticals Inc . (Curran, Jeffrey) [Transferred from okwd on 6/18/2019.] | |
Tuesday, March 05, 2019 | ||
45 | 45 ENTRY of Appearance by Ryan A Ray on behalf of Harvard Drug Group LLC The (Ray, Ryan) [Transferred from okwd on 6/18/2019.] | |
46 | 46 DISCLOSURE STATEMENT - CORPORATE by Harvard Drug Group LLC The . (Ray, Ryan) [Transferred from okwd on 6/18/2019.] | |
47 | 47 UNOPPOSED MOTION for Extension of Time to File Responsive Pleading by Harvard Drug Group LLC The. (Ray, Ryan) [Transferred from okwd on 6/18/2019.] | |
Wednesday, March 06, 2019 | ||
48 | 48 DISCLOSURE STATEMENT - CORPORATE by Amerisourcebergen Corporation Amended . (Huntsman, Susan) [Transferred from okwd on 6/18/2019.] | |
Thursday, March 14, 2019 | ||
49 | 49 RESPONSE in Opposition re38 MOTION to Remand to State Court filed by Endo Health Solutions Inc, Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from okwd on 6/18/2019.] | |
50 | 50 RESPONSE in Opposition re38 MOTION to Remand to State Court filed by McKesson Corp.(Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit CTO, | ||
Att: 2 Exhibit Statement of Interest, | ||
Att: 3 Exhibit Withdrawal | ||
Friday, March 15, 2019 | ||
51 | 51 RESPONSE to Motion re43 JOINT MOTION to Stay Case Proceedings Pending Likely Transfer to Multidistrict Litigation filed by Oklahoma City City of.(Court, Todd) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit Ex. 1 - Order Regarding Remands [#130], | ||
Att: 2 Exhibit Ex. 2 - Case Management Order [#232] | ||
Thursday, March 21, 2019 | ||
52 | 52 REPLY by Plaintiff Oklahoma City City of re38 MOTION to Remand to State Court filed by Oklahoma City City of. (Court, Todd) [Transferred from okwd on 6/18/2019.] | |
Friday, March 22, 2019 | ||
53 | 53 REPLY to Response to Motion re43 JOINT MOTION to Stay Case Proceedings Pending Likely Transfer to Multidistrict Litigation filed by Amerisourcebergen Corporation, Cardinal Health Inc, McKesson Corp. (Campbell, Stuart) [Transferred from okwd on 6/18/2019.] | |
Monday, April 08, 2019 | ||
54 | 54 MOTION for Leave to File Supplemental Authority by Endo Health Solutions Inc, Endo Pharmaceuticals Inc.(Zschiesche, Raymond) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit 1 - Memorandum and Order, | ||
Att: 2 Exhibit 2 - April 4 JPML Transfer Order | ||
Wednesday, May 15, 2019 | ||
55 | 55 MOTION to Expedite Treatment of Motion to Remand by Oklahoma City City of. (Sill, Matthew) [Transferred from okwd on 6/18/2019.] | |
Friday, May 17, 2019 | ||
56 | 56 RESPONSE to Motion re55 MOTION to Expedite Treatment of Motion to Remand (Opposition filed by all Moving Defendants) filed by Endo Health Solutions Inc, Endo Pharmaceuticals Inc.(Zschiesche, Raymond) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit 1-List of Cases | ||
Wednesday, May 22, 2019 | ||
57 | 57 SUPPLEMENT Authority by Oklahoma City City of.(Sill, Matthew) [Transferred from okwd on 6/18/2019.] | |
Att: 1 Exhibit A - Memorandum and Order re remand | ||
Thursday, June 06, 2019 | ||
58 | 58 4 pgs TRANSFER ORDER transferring case to Northern District of Ohio for coordinated or consolidated pretrial proceedings pursuant to 28 USC 1407 and assigned to the Honorable Dan A. Polster. Signed by Clerk of the Panel. (ank) [Transferred from okwd on 6/18/2019.] | |
Tuesday, June 18, 2019 | ||
59 | 59 CASE TRANSFERRED IN from District of Oklahoma Western. Case number 5:19-cv-00076. Original file, certified copy of transfer order and docket sheet received. |